- Home
- INGR vs LEGN Comparison
INGR vs LEGN Comparison
Compare INGR & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INGR
- LEGN
- Stock Information
- Founded
- INGR 1906
- LEGN 2014
- Country
- INGR United States
- LEGN United States
- Employees
- INGR N/A
- LEGN N/A
- Industry
- INGR Packaged Foods
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- INGR Consumer Staples
- LEGN Health Care
- Exchange
- INGR Nasdaq
- LEGN Nasdaq
- Market Cap
- INGR 9.5B
- LEGN 7.8B
- IPO Year
- INGR 1997
- LEGN 2020
- Fundamental
- Price
- INGR $141.79
- LEGN $33.97
- Analyst Decision
- INGR Buy
- LEGN Strong Buy
- Analyst Count
- INGR 6
- LEGN 13
- Target Price
- INGR $155.17
- LEGN $81.54
- AVG Volume (30 Days)
- INGR 440.5K
- LEGN 1.5M
- Earning Date
- INGR 02-04-2025
- LEGN 11-12-2024
- Dividend Yield
- INGR 2.26%
- LEGN N/A
- EPS Growth
- INGR 9.78
- LEGN N/A
- EPS
- INGR 10.26
- LEGN N/A
- Revenue
- INGR $7,551,000,000.00
- LEGN $520,183,000.00
- Revenue This Year
- INGR N/A
- LEGN $120.77
- Revenue Next Year
- INGR $2.39
- LEGN $68.54
- P/E Ratio
- INGR $13.86
- LEGN N/A
- Revenue Growth
- INGR N/A
- LEGN 122.96
- 52 Week Low
- INGR $106.03
- LEGN $32.66
- 52 Week High
- INGR $155.44
- LEGN $70.13
- Technical
- Relative Strength Index (RSI)
- INGR 43.17
- LEGN 31.19
- Support Level
- INGR $141.39
- LEGN $32.66
- Resistance Level
- INGR $146.50
- LEGN $43.96
- Average True Range (ATR)
- INGR 2.45
- LEGN 1.99
- MACD
- INGR -0.84
- LEGN -0.68
- Stochastic Oscillator
- INGR 6.94
- LEGN 11.01
About INGR Ingredion Incorporated
Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company has two main product lines: specialty and core ingredients. Specialty ingredients includes starch-based texturizers, natural alternative sweeteners such as stevia, and plant proteins for alternative dairy and snacks. Core ingredients includes sweeteners, such as high-fructose corn syrup, and commodity starches, such as those used for sustainable packaging.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.